US · 1 sources covering this

Serum Institute Wins Pricing Battle: India Approves 20% Hike On BCG, Measles Vaccines

The latest decision grants the vaccine maker's argument that biological products warrant exemption from average-price-reduction rules applied to other pharmaceutical categories

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

News18Lean R·3h ago
Serum Institute Wins Pricing Battle: India Approves 20% Hike On BCG, Measles Vaccines
The latest decision grants the vaccine maker's argument that biological products warrant exemption from average-price-reduction rules applied to other pharmaceutical categories
Read at News18 →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/8a0b3d5efa1c5fff5efd0571d9ab70b81d512a51"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Serum Institute Wins Pricing Battle: India Approves 20% Hike On BCG, Measles Vaccines"></iframe>

Serum Institute Wins Pricing Battle: India Approves 20% Hike On BCG, Measles Vaccines

How 1 sources are covering this

Serum Institute Wins Pricing Battle: India Approves 20% Hike On BCG, Measles Vaccines

More from US

Totally unacceptable: Trump blames Iran for attacks on 'Indian' ships in Hormuz, slams Tehran over peace deal

Two injured as ceiling collapses at KSRTC complex in Kozhikode

Anyone trying to distort NEET-UG 2026 retest to face full might and weight of law: Cabinet Secretary

Samsung Galaxy S26 price drops by Rs 8,000 without any conditions

Reader

Trust & legal

Across the network